BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vespasiani-Gentilucci U, Gallo P, Dell’Unto C, Volpentesta M, Antonelli-Incalzi R, Picardi A. Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables. World J Gastroenterol 2018; 24(43): 4835-4845 [PMID: 30487694 DOI: 10.3748/wjg.v24.i43.4835]
URL: https://www.wjgnet.com/1007-9327/full/v24/i43/4835.htm
Number Citing Articles
1
Cristiana Bianco, Federica Tavaglione, Stefano Romeo, Luca Valenti. Genetic risk scores and personalization of care in fatty liver diseaseCurrent Opinion in Pharmacology 2021; 61: 6 doi: 10.1016/j.coph.2021.08.014
2
Antonio De Vincentis, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani-Gentilucci. ReplyClinical Gastroenterology and Hepatology 2022; 20(11): 2660 doi: 10.1016/j.cgh.2022.01.010
3
Fatemeh Ghadiri, Abbas Ali Husseini, Oğuzhan Öztaş. A machine-learning approach for nonalcoholic steatohepatitis susceptibility estimationIndian Journal of Gastroenterology 2022; 41(5): 475 doi: 10.1007/s12664-022-01263-2
4
Chiara Zusi, Alessandro Mantovani, Francesca Olivieri, Anita Morandi, Massimiliano Corradi, Emanuele Miraglia Del Giudice, Marco Dauriz, Luca Valenti, Christopher D. Byrne, Giovanni Targher, Claudio Maffeis. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescentsDigestive and Liver Disease 2019; 51(11): 1586 doi: 10.1016/j.dld.2019.05.029
5
Antonio De Vincentis, Federica Tavaglione, Oveis Jamialahmadi, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis ScoresClinical Gastroenterology and Hepatology 2022; 20(3): 658 doi: 10.1016/j.cgh.2021.05.056
6
Antonio De Vincentis, Federica Tavaglione, Rocco Spagnuolo, Roberta Pujia, Dario Tuccinardi, Gianluca Mascianà, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci. Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK BiobankInternational Journal of Obesity 2022; 46(3): 486 doi: 10.1038/s41366-021-01015-w
7
V. Wendy Setiawan, Hugo R. Rosen. Stratification of Residual Risk of HCC Following HCV Clearance With Direct‐Acting Antivirals in Patients With Advanced Fibrosis and CirrhosisHepatology 2020; 72(6): 1897 doi: 10.1002/hep.31639
8
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian PatientsMetabolic Syndrome and Related Disorders 2022; 20(2): 114 doi: 10.1089/met.2020.0104
9
Jia-Min Yang, Yan Sun, Min Wang, Xin-Lei Zhang, Shu-Jing Zhang, Yu-Shan Gao, Lin Chen, Meng-Yao Wu, Lu Zhou, Yu-Mei Zhou, Yue Wang, Feng-Jie Zheng, Yu-Hang Li. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2019; 25(34): 5105-5119 doi: 10.3748/wjg.v25.i34.5105
10
Yuping Zeng, He He, Zhenmei An, Jin Chai. Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver DiseaseDisease Markers 2022; 2022: 1 doi: 10.1155/2022/1254014
11
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenInternational Journal of Molecular Sciences 2019; 20(18): 4444 doi: 10.3390/ijms20184444
12
Kana Daijo, Takashi Nakahara, Yuki Inagaki, Maiko Nanba, Yuno Nishida, Shinsuke Uchikawa, Kenichiro Kodama, Kazuki Oya, Kei Morio, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, C Nelson Hayes, Michio Imamura, Hiroshi Aikata, Hidenori Ochi, Kazuaki Chayama. Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy casesJournal of Gastroenterology and Hepatology 2020; 35(8): 1412 doi: 10.1111/jgh.14968
13
Ângelo Z Mattos, Jose D Debes, Renu Dhanasekaran, Jihane N Benhammou, Marco Arrese, André Luiz V Patrício, Amanda C Zilio, Angelo A Mattos. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challengeWorld Journal of Hepatology 2021; 13(9): 1107-1121 doi: 10.4254/wjh.v13.i9.1107
14
Pierre Nahon, Manon Allaire, Jean-Charles Nault, Valérie Paradis. Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinomaHepatic Oncology 2020; 7(4) doi: 10.2217/hep-2020-0017
15
Shan Tang, Jing Zhang, Ting-Ting Mei, Hai-Qing Guo, Xin-Huan Wei, Wen-Yan Zhang, Ya-Li Liu, Shan Liang, Zuo-Peng Fan, Li-Xia Ma, Wei Lin, Yi-Rong Liu, Li-Xia Qiu, Hai-Bin Yu. Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysisBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6173-4
16
György M. Buzás. Helicobacter pylori and non-alcoholic fatty liver diseaseMinerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02671-9
17
Jun Wang, David V. Conti, David Bogumil, Xin Sheng, Mazen Noureddin, Lynne R. Wilkens, Loic Le Marchand, Hugo R. Rosen, Christopher A. Haiman, Veronica Wendy Setiawan. Association of Genetic Risk Score With NAFLD in An Ethnically Diverse CohortHepatology Communications 2021; 5(10): 1689 doi: 10.1002/hep4.1751
18
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng. Association of metabolic dysfunction-associated fatty liver disease with kidney diseaseNature Reviews Nephrology 2022; 18(4): 259 doi: 10.1038/s41581-021-00519-y
19
Monica A. Tincopa. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitisEndocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.177
20
Antonio De Vincentis, Rosellina Margherita Mancina, Jussi Pihlajamäki, Ville Männistö, Salvatore Petta, Paola Dongiovanni, Anna Ludovica Fracanzani, Luca Valenti, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani‐Gentilucci. Genetic variants in the MTHFR are not associated with fatty liver diseaseLiver International 2020; 40(8): 1934 doi: 10.1111/liv.14543
21
Aynur Unalp‐Arida, Constance E. Ruhl. Patatin‐Like Phospholipase Domain‐Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. PopulationHepatology 2020; 71(3): 820 doi: 10.1002/hep.31032
22
Li-jie Chen, Jing Guo, Song-xia Zhang, Ying Xu, Qing Zhao, Wei Zhang, Jian Xiao, Yao Chen. Sirtuin3 rs28365927 functional variant confers to the high risk of non-alcoholic fatty liver disease in Chinese Han populationLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01520-x
23
Shubham Jain, Ravi Thanage, Falguni Panchal, Pravin M. Rathi, Renuka Munshi, Suhas S. Udgirkar, Qais Q. Contractor, Sanjay J. Chandnani, Nair P. Sujit, Partha Debnath, Anupam Singh. Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?Journal of Clinical and Experimental Hepatology 2021; 11(4): 466 doi: 10.1016/j.jceh.2020.10.003
24
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Stefan Stender. Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General PopulationHepatology 2020; 72(3): 845 doi: 10.1002/hep.31238
25
Francesca Terracciani, Andrea Falcomatà, Paolo Gallo, Antonio Picardi, Umberto Vespasiani-Gentilucci. Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkersJournal of Physiology and Biochemistry 2023; 79(4): 851 doi: 10.1007/s13105-022-00934-0
26
Nataša Milošević, Maja Milanović, Jan Sudji, Dragana Bosić Živanović, Stefan Stojanoski, Bojan Vuković, Nataša Milić, Milica Medić Stojanoska. Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans?Environmental Science and Pollution Research 2020; 27(1): 772 doi: 10.1007/s11356-019-06831-2
27
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)Cureus 2021;  doi: 10.7759/cureus.20776
28
Jaehyun Bae, Byung-Wan Lee. Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver DiseaseBiomedicines 2023; 11(7): 1928 doi: 10.3390/biomedicines11071928
29
Stefano Ministrini, Fabrizio Montecucco, Amirhossein Sahebkar, Federico Carbone. Macrophages in the pathophysiology of NAFLD: The role of sex differencesEuropean Journal of Clinical Investigation 2020; 50(6) doi: 10.1111/eci.13236